{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:46:27Z","timestamp":1762508787791,"version":"3.41.2"},"reference-count":25,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100019428","name":"Nabriva Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2022,8,16]]},"abstract":"<jats:p>\n            Lefamulin, a semisynthetic pleuromutilin antibiotic approved in the United States, Canada, and Europe for intravenous and oral treatment of community-acquired bacterial pneumonia, is highly active\n            <jats:italic>in vitro<\/jats:italic>\n            against bacterial pathogens that cause sexually transmitted infections (STIs), including multidrug-resistant strains of\n            <jats:named-content content-type=\"genus-species\">Neisseria gonorrhoeae<\/jats:named-content>\n            ,\n            <jats:named-content content-type=\"genus-species\">Chlamydia trachomatis<\/jats:named-content>\n            , and\n            <jats:named-content content-type=\"genus-species\">Mycoplasma genitalium<\/jats:named-content>\n            . This nonclinical study used quantitative whole-body autoradiography (QWBA) and qualitative tape-transfer microautoradiography (MARG) to investigate lefamulin distribution into urogenital tract tissues down to a cellular level in male and female rats.\n          <\/jats:p>","DOI":"10.1128\/aac.00355-22","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T13:09:19Z","timestamp":1657544959000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["Tissue Distribution of [\n            <sup>14<\/sup>\n            C]-Lefamulin into the Urogenital Tract in Rats"],"prefix":"10.1128","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4863-7559","authenticated-orcid":true,"given":"Wolfgang W.","family":"Wicha","sequence":"first","affiliation":[{"name":"Nabriva Therapeutics GmbH, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Henson","sequence":"additional","affiliation":[{"name":"Pharmaron UK Ltd., Rushden, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Webbley","sequence":"additional","affiliation":[{"name":"Pharmaron UK Ltd., Rushden, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P.","family":"Gelone","sequence":"additional","affiliation":[{"name":"Nabriva Therapeutics US, Inc., Fort Washington, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"World Health Organization. 2016. Sexually transmitted infections (STIs). http:\/\/www.who.int\/mediacentre\/factsheets\/fs110\/en\/. Accessed March 9."},{"key":"e_1_3_2_3_2","unstructured":"Centers for Disease Control and Prevention. 2018. Sexually transmitted disease surveillance 2018 on US Department of Health and Human Services. https:\/\/www.cdc.gov\/std\/stats18\/STDSurveillance2018-full-report.pdf. Accessed March 9."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta20220"},{"key":"e_1_3_2_5_2","unstructured":"Centers for Disease Control and Prevention. 2015. 2015 Sexually transmitted diseases treatment guidelines. https:\/\/www.cdc.gov\/std\/tg2015\/emerging.htm#myco. Accessed March 9."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-00805-7"},{"key":"e_1_3_2_7_2","unstructured":"National Institute of Allergy and Infectious Diseases. 2016. Sexually transmitted diseases (STD) disease-specific research. https:\/\/www.niaid.nih.gov\/diseases-conditions\/std-research. Accessed February 11."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix198"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix145"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105911"},{"key":"e_1_3_2_11_2","volume-title":"Xenleta\u2122.","author":"Anonymous","year":"2019","unstructured":"Anonymous. 2019. Xenleta\u2122. Nabriva Therapeutics US, Inc., King of Prussia, PA."},{"key":"e_1_3_2_12_2","volume-title":"Xenleta.","author":"Anonymous","year":"2020","unstructured":"Anonymous. 2020. Xenleta. Nabriva Therapeutics Ireland DAC, Dublin, Ireland."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.15468"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep39004"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz090"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01497-17"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02380-17"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv442"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz086"},{"key":"e_1_3_2_20_2","first-page":"S240","article-title":"Pharmacokinetic, mass balance and tissue distribution of [14C]-BC-3781 in non-pigmented rats","volume":"16","author":"Wicha WW","year":"2010","unstructured":"Wicha WW, Ivezic-Schoenfeld Z, Novak R. 2010. Pharmacokinetic, mass balance and tissue distribution of [14C]-BC-3781 in non-pigmented rats. Clin Microbiol Infect 16:S240\u2013S241. Poster P909.","journal-title":"Clin Microbiol Infect"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01644-18"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6950a6"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00357-13"},{"key":"e_1_3_2_24_2","unstructured":"Featherstone L. 2014. Code of practice for the housing and care of animals bred supplied or used for scientific purposes on United Kingdom Home Office. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/388895\/COPAnimalsFullPrint.pdf. Accessed August 30."},{"key":"e_1_3_2_25_2","first-page":"1","article-title":"Studies on the distribution and fate of S35-labelled benzylpenicillin in the body","volume":"118","author":"Ullberg S","year":"1954","unstructured":"Ullberg S. 1954. Studies on the distribution and fate of S35-labelled benzylpenicillin in the body. Acta Radiol Suppl 118:1\u2013110.","journal-title":"Acta Radiol Suppl"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2004.09.001"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00355-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00355-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T13:05:47Z","timestamp":1660655147000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00355-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,16]]}},"alternative-id":["10.1128\/aac.00355-22"],"URL":"https:\/\/doi.org\/10.1128\/aac.00355-22","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"type":"print","value":"0066-4804"},{"type":"electronic","value":"1098-6596"}],"subject":[],"published":{"date-parts":[[2022,8,16]]},"assertion":[{"value":"2022-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00355-22"}}